Crescendo Biologics UK
Crescendo Biologics is a biopharmaceutical company developing potent, truly differentiated Humabody®therapeutics in oncology with a focus on innovative targeted T-cell approaches.
Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel bispecific PSMA-targeted T-cell engager for the selective activation of tumour-specific T-cells exclusively within the tumour microenvironment, thereby avoiding systemic toxicity.
Crescendo Biologics is a biopharmaceutical company developing potent, truly differentiated Humabody®therapeutics in oncology with a focus on innovative targeted T-cell approaches.
Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel bispecific PSMA-targeted T-cell engager for the selective activation of tumour-specific T-cells exclusively within the tumour microenvironment, thereby avoiding systemic toxicity.
Your career starts on Magnet.me
Create a profile and receive connection requests from interested companies.
Jobs
Interesting to know
This company page was generated automatically and therefore features only limited information. Find out more about Crescendo Biologics UK on their company website:
This company page was generated automatically and therefore features only limited information. Find out more about Crescendo Biologics UK on their company website:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.